Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018919 |
---|---|
Receipt number | R000021856 |
Scientific Title | Phase II trial of biweekly THP-COP therapy for patients with peripheral T-cell lymphomas. |
Date of disclosure of the study information | 2015/09/05 |
Last modified on | 2018/05/31 20:20:06 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/09/05 22:31:48 | ||
2 | Update | 2016/09/05 09:27:50 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization Organization Organization Organization1 Address1 Tel1 Institutions |
|
3 | Update | 2018/05/31 20:20:06 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |